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Sunscreens have been employed on daily skin care for centuries. Their role in protecting the skin from sun
damage, avoiding accelerated photoaging and even limiting the risk of development of skin cancer is unques-
tionable. Although several chemical and physical filters are approved as sunscreens for human use, their safety
profile is dependent on their concentration in the formulation which governs their acceptance by the regulatory
agencies. A strategic delivery of such molecules should provide a UV protection and limit the skin penetration.
Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) may offer an alternative approach to
achieve a synergistic effect on the UV protection when loaded with sunscreens as particles themselves also have a
UV light scattering effect. Besides, the lipid character of SLN and NLC improves the encapsulation of lipophilic
compounds, with enhanced loading capacity. Silica nanoparticles have also been employed in sunscreen for-
mulations. Due to the formed sol-gel complexes, which covalently entrap sunscreen molecules, a controlled
release is also achieved. In the present work, we have developed a new sunscreen formulation composed of hybrid
SLN-Silica particles loaded with octyl methoxycinnamate (Parsol®MCX), and their further incorporation into a
hydrogel for skin administration. Hybrid SLN-silica particles of 210.0  3.341 nm of mean size, polydispersity
below 0.3, zeta potential of ca. |7| mV, loading capacity of 19.9% and encapsulation efficiency of 98.3% have
been produced. Despite the slight negative surface charge, the developed hybrid nanoparticles remained physi-
cochemically stable over the study period. Turbiscan transmission profiles confirmed the colloidal stability of the
formulations under stress conditions. The texture profile analysis of Parsol-SLN and Parsol-SLN-Si revealed semi-
solid properties (e.g. adhesiveness, hardness, cohesiveness, springiness, gumminess, chewiness, resilience) suit-
able for topical application, together with the bioadhesiveness in the skin of pig ears. The non-irritation profile of
the hybrid nanoparticles before and after dispersion into Carbopol hydrogels was confirmed by HET-CAM test.1. Introduction
Sunscreens or UV blockers are commonly used to minimize sunburns,
which are responsible for an early onset of skin aging and even for the
enhanced risk of both melanoma and non-melanoma skin cancer [1].
Sunscreens are mainly classified in two categories – organic versus
inorganic sunscreens. The former comprise molecules as salicylates
which absorb the UV radiation in a relatively narrow wavelength when@gmail.com (E.B. Souto).
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is an open access article under tdirectly applied onto the skin [2]. These molecules undergo a relatively
fast photodegradation thereby showing short lifetime, frequently causing
allergic reactions and may even be absorbed by the skin [3, 4]. Inorganic
sunscreens (e.g. titanium dioxide, zinc oxide) exhibit a wider UV ab-
sorption band as they combine absorption and scattering of UVA and
UVB radiations. A synergistic (or at least an additive) effect may be ob-
tained when combining organic and inorganic UV blockers in a topical
formulation. Another approach to improve the performance of both typesApril 2020
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lipid nanoparticles (SLN) [5, 6, 7], silica nanoparticles (Si-NPs) [8, 9], as
nanoparticles also have light scattering capacity [6]. SLN are composed
of biodegradable and biocompatible lipids (e.g. triglycerides, fatty acids,
waxes) [10], whereas Si-NPs result from the co-condensation of orga-
notrialkoxysilane monomer and silica monomer (e.g. TEOS, tetraethox-
ysilane), using ethanol in ammonia as the organic solvent to obtain
Si-NPs in suspension [11, 12]. Depending on the lipophilic character of
the sunscreen, a high loading capacity can be achieved either by physical
encapsulation within the nanoparticle matrix or by chemical covalent
bonding. Hydrophobic sunscreen molecules can be easily loaded within
the lipid core of SLN or formulated in oil/water (o/w) polymerized
microemulsions during the production of silica particles. Hydrophilic
sunscreens can be incorporated through a reverse water/oil (w/o)
microemulsion process [13, 14].
Parsol® MCX (2-ethylhexyl 4-methoxycinnamate or octyl methox-
ycinnamate) is a water-resistant, colorless UVB filter, frequently found in
combination with other sunscreens. It is easily formulated in the lipid
phase of cosmetic products, being thereby a good candidate for the
loading into nanoparticles. To circumvent the use of organic solvents, we
propose a new type of nanoparticles – hybrid nanoparticles – composed
of lipids and silica, to be loaded with octyl methoxycinnamate (Parsol®
MCX). For topical application, a semi-solid hydrogel formulation has also
been developed with a gel forming agent (Carbopol® 971); the irritation
profile of particles before and after dispersion into hydrogels has been
analysed by HET-CAM test.
2. Materials and methods
2.1. Materials
Parsol® MCX (2-ethylhexyl 4-methoxycinnamate or octyl methox-
ycinnamate) was purchased from Acofarma (Barcelona, Spain). Tet-
raethyl orthosilicate (TEOS, 98%) was purchased from Merck
(Darmstad, Germany). Cetyl palmitate (solid lipid) was purchased
from Sigma-Aldrich (Portugal). Tego Care® 450 (surfactant) was ob-
tained from Evonik Industries (Germany). Carbopol® 971P NF Polymer
was purchased from Lubrizol (Wickliffe, USA). MilliQ Plus system
(Millipore, Germany) was used as source of water of high purity used
in the study.Table 1. Composition of the developed formulations (w/w %).2.2. Preparation of blank-SLN and Parsol-SLN
High shear homogenization method was used for the production of
SLN (blank-SLN) [15]. Particles were composed of cetyl palmitate
(solid lipid) stabilized with polyglyceryl-3 methylglucose distearate
(Tego Care®450) as surfactant. Briefly, cetyl palmitate was melted in a
beaker heated at 65 C. The aqueous phase, composed of water and
Tego Care®450, was heated up to the same temperature. Both phases
were mixed together under stirring at 10 000 rpm, using an
Ultra-Turrax T25 for 15 min. The dispersions were cooled down under
ice bath for 10 min, allowing the lipid to recrystallize and generate
blank-SLN. For the Parsol® MCX loaded hybrid nanoparticles (Par-
sol-SLN), Parsol® and TEOS were added to the melted cetyl palmitate
prior to the hot shear emulsification, following the same process as
described for blank-SLN. Table 1 lists the composition and concen-
tration for each developed formulation.Components Blank SLN Parsol-SLN Parsol-SLN-Si
Cetyl palmitate 5.0 4.0 4.0
Tego Care® 450 1.0 1.0 1.0
TEOS - - 1.0
Parsol - 1.0 1.0
Water 84.0 84.0 83.0
Si: Silica coating.2.3. Quantification of encapsulation parameters
The encapsulation parameters, i.e. encapsulation efficiency (EE) and
loading capacity (LC), of octyl methoxycinnamate (OMC, Parsol® MCX)




 100 (1)LC%¼ WOMC Ws
WOMC Ws þWL  100 (2)
whereWOMC is the mass of octyl methoxycinnamate (OMC, Parsol®MCX)
weighted to prepare SLN, WL is the mass of cetyl palmitate weighted to
prepare SLN, andWs is the mass of octyl methoxycinnamate quantified at
310 nm in the supernatant. Briefly, a volume of Parsol-SLN was ultra-
centrifuged for 1 h at 100,000 g in a ultracentrifuge (Beckman Op-
tima™ XL, Indianapolis, USA), after which OMC was quantified in the
supernatant in a UV spectrophotometer (Shimadzu UV-1601, Shimadzu,
Cornaredo, Italy).
2.4. Incorporation of Parsol-loaded hybrid nanoparticles in hydrogels
Hybrid nanoparticles were incorporated in hydrogels to achieve
suitable viscosity for topical application. The preparation of hydrogels
consisted in the addition of 1.0% (w/v) of the gel forming agent (Car-
bopol® 971) to 99% of distilled water under gentle magnetic stirring at
300 rpm. Then, the aqueous dispersion was neutralized using a NaOH
solution (10.0%) to reach the pH of 7.0. SLN formulations were incor-
porated into hydrogels adding 20.0 mL of SLN dispersions to 10.0 g of
Carbopol hydrogels followed by high speed stirrer (Cito-Unguator, Gaco
International, UK) for 1 min, followed by 30 s in the ultrasound bath for
the eventual removal of air bubbles.
2.5. Particle size analysis and zeta potential (ZP) measurements
Dynamic light scattering (DLS, Zetasizer Nano ZS, Malvern In-
struments, Malvern, UK) was used to characterize SLN dispersions with
respect to the mean particle size, polydispersity index (PI) and zeta po-
tential (ZP). For the determination of the mean particle size and PI, each
dispersion was diluted in ultra-purified water at a ratio that avoids par-
ticle scattering (1:100) and the mean size and PI were assessed at a fixed
angle of 173. Measurements were done at the temperature of 25 C. For
ZP analysis, nanoparticles were also diluted at the same ratio (1:100)
with purified water of conductivity adjusted to 50 μS.cm1 by adding
0.9% NaCl solution. ZP was measured by laser Doppler electrophoresis at
25 C. Size parameters and ZP were recorded at pre-determined time
intervals (day 0, and 7, 15 and 30 days after production). Each recorded
value was obtained from the average of three measurements (each
measurement results from the average of 10 runs).
2.6. Long-term physical stability of hybrid nanoparticles by TurbiscanLab®
analysis
The physical stability of SLN dispersions was monitored using an
optical analyser TurbiscanLab® (Formulaction, France), composed of a
near-infrared light source (880 nm), and two synchronous transmission
(T) and backscattering (BS) detectors. Experiments were conducted at 25
C. The SLN dispersions were placed in a cylindrical glass cell. The T
detector received the light crossing SLN dispersions, while the BS
T. Andreani et al. Heliyon 6 (2020) e03831detector received the light scattered backwards. T and BS were recorded
each 40 μm, 3 times over a period of 10 min, from the scanning of the
entire height of the sample by the detection head.
2.7. Differential scanning calorimetry (DSC)
A Mettler DSC 823e (Mettler Toledo, Spain) was used for the DSC
measurements. Prior to analysis, indium of purity 99.95% (Fluka,
Switzerland) was used to calibrate the device. Accurately weighted mass
of 1.0–2.0 mg of cetyl palmitate, octyl methoxycinnamate (Parsol®
MCX), or an equivalent amount of lipid formulated as hybrid nano-
particles, were weighted in aluminium pan of 40.0 μl, which were then
cold sealed. An empty pan was used as reference. Heating curves for the
bulk materials were recorded with a scan rate of 5.0ºC/min from 25.0 to
200.0 C and then cooled down to 25.0 C, using liquid nitrogen. For the
analysis of SLN formulations, heating curves were recorded from 25.0 C
to 85.0 C following cooling down to 25.0 C, at a scan rate of 5.0ºC/min.
The Mettler STARe V 9.01 DB software (Mettler Toledo, Spain) was used
for the collection and storage of the data of peak areas.
2.8. Bioadhesion analysis of hybrid nanoparticles and hydrogels
The Texture Analyzer TAXT Plus (Stable Micro Systems Ltd., Surrey,
UK) was used for the characterization of the bioadhesive profile of the
developed formulations, using skin from fresh pig ears as biological
model. The ears were obtained from a local slaughterhouse, following
their preparation and set-up for the experiments according to previously
published work [16, 17]. Prior the experiments, the skin ears were
carefully cleaned with distilled water and frozen at -20.0 C. For the
experiment, nanoparticles were frozen at -80.0 C for 24 h, and thendried
in a freeze dryer during 48 h at 0.06mbar (Labconco FreeZon®Freeze Dry
Systems). During the analysis, the skin was kept in the lower platform of
the texture analyzer, while the samples were fixed to the upper probe
(10.0 mm of diameter) using double-side adhesive. Nanoparticles and
skin were kept in close contact for 60 s at 32.0  0.5 C followed by the
elevation of the probe at 0.5 mm/s. During the experiment, before the
analysis, the biological samples were maintained in a physiological saline
solution composed of NaCl 0.9% (w/v) in an ice bath. The bioadhesive
properties of samples were expressed as tensile work (g.s), which has
been obtained from the area under the force-time curve, as recommended
[16]. For comparative analysis, Carbopol 971 hydrogel (C971) was used
as reference due to its well-known mucoadhesive properties. All samples
were analyzed in quintuplicate.
2.9. Texture profile analysis (TPA) of hydrogels
TPA analysis was carried out in a Texture Analyzer TAXT Plus (Stable
Micro Systems Ltd., Surrey, UK) to evaluate the mechanical properties
(hardness, adhesiveness and cohesiveness), as well as the springiness,
gumminess, chewiness and resilience of the hydrogels. Hardness (g) was
measured as the maximal stress reached during the first compression. The
adhesiveness (g.s) was obtained as the area over the negative stress-strain
curve after the first compression (work/volume). The cohesiveness was
determined as the ratio of second compression and the first compression.
Chewiness was calculated as the product of gumminess and springiness,
which is the same as the product of hardness £ cohesiveness  spring-
iness. From the product of hardness £ cohesiveness, gumminess was
obtained. Springiness is a textural parameter related to the elasticity of
the sample. Resilience was obtained as the ratio between energy released
during recovery from deformation and the energy required for the
deformation. Briefly, gels (10.0 g) were compressed uniaxially twice
using an analytical probe at 1.0 mm/s to a predefined depth of 10.0 mm
at a speed of 0.5 mm/s for each sample. The second compression was
applied 5 s after the first one. Carbopol 971 gel (C971) was also used as
gel reference for comparative analysis. All formulations were analysed in
sextuplicate at 32.0 C.3
2.10. In-vitro Hen's egg test on the chorioallantoic membrane (HET-CAM)
To characterize the non-irritation profile of the hybrid nanoparticles
before and after their dispersion into Carbopol hydrogels, the HET-CAM
test has been performed as described before [18, 19, 20]. Eggs were
firstly incubated at 38  0.5 C for a period of 10 days. The chorioal-
lantoic membrane of the eggs was carefully removed using fine-tipped
forceps to expose CAM. Parsol-SLN-Si were placed onto the embryo-
nated hen's egg membrane, and the effects of nanoparticles monitored for
300 s. To characterize the semi-solid formulations (300 μL), these were
firstly diluted in distilled water prior to their application onto the CAM of
the eggs. As the positive control (for vascular hemorrhage and lysis), a
volume of 300 μL of sodium hydroxide solution (0.1 M) was used. As the
negative control, a volume of 300 μL of NaCl solution (0.9 wt.%) was
used. The assays were performed in triplicate. Haemorrhage (H), lysis (L)
and coagulation (C) were monitored over 300 s, recording the onset time
of these three events. The standard irritation scores were calculated using
the following equation:
300 [IS] ¼ 5 [301  H] þ 7 [301  L] þ 9 [301  C]
where IS stands for the irritation score, H for the onset time (in seconds)
of bleeding, L for the onset time (in seconds) of lysis, C for the onset time
(in seconds) of coagulation. The irritation profile was scored according to
the following scale: from 0 to 0.9 as non-irritant; from 1 to 4.9 as slightly
irritant; from 5 to 8.9 as moderately irritant; from 9 to 21 as strongly
irritating.
2.11. Determination of the sun protection factor
The SPF of Parsol-SLN-Si was determined as described by Barbosa
et al. [7], measured between 290 and 320 nm (UVB wavelength range),
with increments of 5 nm. To estimate the SPF value of the developed
formulation, Mansur et al. have proposed a mathematical model,




EEðλÞ  IðλÞ  AbsðλÞ
in which CF stands for the correction factor, EEðλÞ stands for the spectrum
of erythemal effect, IðλÞ for the spectrum of solar intensity and AbsðλÞ for
the sunscreen absorbance. As the EEðλÞ and IðλÞ are constant values, the
SPF of the Parsol-SLN-Si could be estimated. Three determinations were
made at each point.
2.12. Statistical analysis
All experiments were performed in triplicate, if not otherwise stated.
A one-way analysis of variance (ANOVA) was used to analyse the sta-
tistical differences, considered significant for p-values below 0.05.
3. Results and discussion
The size parameters (mean particle size and PI) and zeta potential (PI)
were compared among the three developed formulations when stored at
room temperature over time. While blank SLN showed the lowest mean
particle size and PI and higher ZP values, no statistically significant dif-
ferences have been encountered for the three formulations (Table 2). On
the day of the production, the loading of SLN with the sunscreen slightly
increased the mean size and the PI (211.4  1.085 nm and PI of 0.104 
0.111 for blank-SLN, and 243.1  1.493 nm and PI of 0.300  0.041 for
Parsol-SLN). Freshly prepared Parsol-SLN resulted in the LC of 19.9% and
EE of 98.3%, values attributed to the water-insolubility of the octyl
methoxycinnamate thus with low partition into the water phase during the
production of SLN [10]. High encapsulation parameters (LC and EE) are
usually recorded for poorly water-soluble and lipophilic active ingredients
Figure 1. Thermograms of bulk cetyl palmitate, blank SLN, Parsol-SLN and
Parsol-SLN coated with colloidal silica.
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parameters of Parsol-SLN (mean particle size of 210.0  3.341 nm and PI
< 0.300). Regardless the obtained mean particle size and polydispersity
index, both non-coated and coated-particles could be used for topical
application. Particles remain within a narrow size range over time. These
results agree with previous reports, describing that the addition of
silica-based polymers can shorten the distance between lipids and sur-
factants, leading to improved packing of nanoparticle surface and reduced
particle size [24, 25]. Changes in the ZP values clearly indicate the pres-
ence of silica onto the surface of the particles. The particles can be stabi-
lised in aqueous dispersion by different mechanisms, i.e. electrostatic
(measured by ZP) and/or steric (hydrophilic chains of surfactants). The
low zeta potential did not compromise the stability over time due to the
presence of the emulsifying and reinforcement of the particle stability with
the silica coating.
ZP was measured after diluting the original dispersion in water of con-
ductivity previously adjusted to 50.0 μS/cm. Blank SLN showed the highest
ZP values, although slightly negative, given the presence of the non-ionic
emulsifier (Tego Care®450) onto the surface of the particles. The loading
of SLN with Parsol did not significantly influence the ZP values, but the
coating with TEOS decreased the surface electrical charge of the particles
towards positive values after one month of storage at room temperature.
These results confirm the successful development of hybrid nanoparticles.
The literature reports that ZP values above |30| mV are preferential to ach-
ieve higher electrostatic stability of colloidal dispersions, |5|mV to |15|mV
suggest of a rangeof limitedflocculationwhile values between |3|mVto |5|
mVtheflocculationtendstoamaximum[26,27].Whileexhibitingaslightly
negative surface charge, the developed hybrid nanoparticles remained
physicochemically stable over the study period.
Polymorphic transitions may occur within the lipid matrix of SLN,
which may contribute to expel the drug from the carriers during storage.
To tackle the risk of phase transitions, analysis of the crystallinity profile
of SLN is needed which will also provide information on the loading
capacity of the system for a specific drug and any potential interactions
with excipients [28, 29]. The loading capacity of SLN decreases in the
following sequence: supercooled melt, followed by the amorphous
α-modification, the metastable β0-modification, and the most crystalline
β-modification [30, 31]. The opposite happens with the lipid packing
density and the thermodynamic stability. Figure 1 shows the thermo-
grams of bulk cetyl palmitate, blank SLN, Parsol-SLN and Parsol-SLN
coated with colloidal silica. The melting point of bulk cetyl palmitate
was recorded between 56 C and 57 C, depicting a sharp peak. The onset
temperature and enthalpy decreased with the use of the wax in SLN
production, followed by the loading of particles with Parsol and the
respective coating. These results translate a less organized lipid matrixTable 2. Particle size parameters and zeta potential of Blank SLN, Parsol-SLN and Pa
Blank SLN Z-Ave (nm)  SD
Day 0 211.4  1.085
Day 7 215.2  2.014
Day 15 222.5  1.251
Day 30 213.4  1.932
Parsol-SLN Z-Ave (nm)  SD
Day 0 243.1  1.493
Day 7 248.4  5.200
Day 15 248.1  2.173
Day 30 248.0  4.551
Parsol-SLN-Si Z-Ave (nm)  SD
Day 0 210.0  3.341
Day 7 256.4  5.369
Day 15 214.3  1.823
Day 30 207.2  5.595
SD, standard deviation (n ¼ 3 run; each run ¼ 10 measurements); day ¼ 0 stands fo
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mostly in the β0-modification, which contributes to maintain the drug
loaded in the SLN [30, 32, 33].
To confirm the long-term stability of the developed formulations,
Turbiscan transmission profiles have been recorded. This type of mea-
surement is based on the discrepancy of migration or coalescence of
analyzed particles with further dissimilarity on the amount of lightrsol-SLN-Si at pre-determined time intervals for a period of 30 days.
PI  SD ZP (mV)  SD
0.104  0.111 -12.9  0.331
0.163  0.028 -11.4  0.174
0.174  0.031 -11.2  0.531
0.179  0.005 -10.3  0.187
PI  SD ZP (mV)  SD
0.300  0.041 -9.6  0.000
0.326  0.044 -9.5  0.119
0.361  0.022 -8.5  0.389
0.353  0.011 -12.0  0.236
PI SD ZP (mV)  SD
0.264  0.009 -6.93  0.745
0.396  0.009 -5.19  0.134
0.290  0.026 -8.03  0.435
0.287  0.027 þ4.02  0.792
r the day of production.
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scattered is presented as positive or negative variations versus time which
is according to the pattern of particle migration. For example, if particles
migrate in direction of the bottom of the assay tube, the concentration of
those will increase at the center and bottom and decrease at the top [37].
As a result, the light will be less scattered at the top and more trans-
mitted, resulting in a first negative peak with following expansion to
positive values in consequence of growing concentrations of particles and
thus increasing backscattered light.
In the present study, the samples were tested on a tubewith the registry
beginning from the bottom and a mark was made at a height of 20.0 mm.
Three samples were employed from each formulation corresponding to
separate times of measurement: at day 0, day 7 and day 15. For SLN, ho-
mogenous and almost without variation values for the three samples were
registered; approximately fromtheverybeginningof the tubemeasurement
the backscattering light had a constant value of 80.0%, with differences
noticeable only after the given mark (Figure 2 a). For Parsol-SLN an even
softly beginning was seen with small loss values - 76.0%–80.0% of back-
scattered light - but homogenous although even after the 20.0 mm mark
(Figure 2 b). For Parsol-SLN-Si the values were homogeneous, and the par-
ticles showedsimilarbehavior, butoverall valueswereslightly lower - about
70.0% of light scattering - below 20.0mmmark. Above the givenmark, the
values felldownsignificantly.Suchfindingsconfirmthestabilityof the three
tested formulations. Blank-SLN and Parsol-SLN showed improved colloidal
stability over a period of 15 days after production.
The texture profile analysis of Parsol-SLN and Parsol-SLN-Si was car-
ried out recording the adhesiveness, hardness, cohesiveness, springiness,
gumminess, chewiness and the resilience (Table 3). For hardness param-
eter,Parsol-SLN-Siexhibitedthe lowestvalue,whichwas foundbetter than
Parsol-SLNas it represents the forceneeded topress the formulationuntil it
offers thetopresistancetocompression[38].Parsol-SLN-Sifittedbetter the
desired profile for a topical application which requires a small force to
spread the formulation onto the skin. Silica could apparently improve the
texture properties for a topical application. With respect to adhesiveness,
Parsol-SLNexhibitedahighervaluethanParsol-SLN-Sihoweverattributed
to the hardness parameter due to the apparent improved adhesivenessFigure 2. Turbiscan transmission profiles of (a) blank SLN, (b)
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createdbythehighestpressurebetweenthe formulationandthebaseof the
apparatus. Both formulations presented the same values for Springiness
parameter revealing the same capacity to return to the initial design after
deformation. Cohesiveness, which translates the product adhesiveness to
itself or, in other terms, physical stability between molecules was almost
the same for both formulations but Parsol-SLN-Si showed a slightly higher
value. Both gumminess and chewiness were 1.5-fold higher in Parsol-SLN
formulation, corroborating with the desired values observed for
Parsol-SLN-Si formulation. The higher the hardness, the higher the gum-
miness and chewiness. Resilience parameter was almost the same for both
formulationsbeingslightlysmaller forParsol-SLN-Siwhichdemonstratesa
lower capacity against recovering the original height [39, 40, 41, 42].
Two different semi-solid formulations were produced by dispersing
Parsol-SLNor Parsol-SLN-Si in Carbopol 917 hydrogels to achieve suitable
viscosity for topical use. The bioadhesiveness of semi-solids were
compared with the original dispersions and with a standard Carbopol 91
hydrogel (Table 4). Skin of pig ears has been used as ex-vivo model,
following approval of the Ethics Committee (UNESP/Ethics Committee/
Parsol-SLN/2015). Bioadhesiveness increased in the following order:
C917 (6.69g.s)<Parsol-SLN (7.13g.s)<Parsol-SLNhydrogel (9.19g.s)<
Parsol-SLN-Si hydrogel (10.46 g.s)¼ Parsol-SLN-Si (10.46 g.s). Improved
bioadhesivenesswas achievedwith the use of SLN in the hydrogels, which
is in agreement with previous reports [39, 40]. Both Parsol-SLN-Si and
Parsol-SLN-Si hydrogel had peak values for bioadhesiveness which put in
evidence the role of SLN-silica combination as enhancer of this parameter
in such a fashion that even an equal formulation but with inclusion in a
hydrogel does not offer a better adhesiveness profile.
As the eye is more sensitive than healthy skin, and are commonly in
contact with cosmetic and other UV blockers, the HET-CAM test has been
run to measure the potential risk of irritation of Parsol-SLN-Si before and
after their dispersion into hydrogels. This test consists on the determi-
nation of the risk of irritation by applying the formulation under study
onto the chorion-allantoic membrane (CAM) of the chicken egg, and
following determining hyperemia, hemorrhage, coagulation and lysis on
the day 10 of the period of incubation [18, 19, 20]. It has been recently
used as irritation test of sunscreen formulations [7]. No vascular eventsParsol-SLN and (c) Parsol-SLN coated with colloidal silica.
Table 3. Texture profile analysis (hardness (g), adhesiveness (g.s), springiness, cohesiveness, gumminess, chewiness and resilience) of Parsol-loaded SLN and Parsol-
loaded SLN coated with silica gels (n ¼ 3).
Hardness Adhesiveness Springiness Cohesiveness Gumminess Chewiness Resilience
Parsol-SLN 6.52  0.58 18.84  4.39 0.85  0.007 0.706  0.021 1.62  0.22 1.38  0.18 0.18  0.04
Parsol-SLN-Si 3.62  0.13 11.55  0.36 0.85  0.01 0.74  0.02 1.07  0.05 0.91  0.05 0.15  0.01
Table 4. Bioadhesiveness (g.s) of Parsol-SLN and Parsol-SLN-Si before and after
formulated in Carbopol C917 hydrogels in comparison to blank Carbopol C917
hydrogel.
Formulation Bioadhesiveness (g.s)
C917 6.69  0.64
Parsol-SLN 7.13  2.28
Parsol-SLN hydrogel 9.19  0.27
Parsol-SLN-Si hydrogel 10.46  0.60
Parsol-SLN-Si 10.46  0.51
T. Andreani et al. Heliyon 6 (2020) e03831were seen over the 300 s of the assay. The IS of 0.38 was recorded for the
hydrogels containing particles, and of 0.39 for the Parsol-SLN-Si. Pure
Carbopol hydrogels revealed an IS of 0.00.
According to the literature, concentration of 1% (w/w) of octyl
methoxycinnamate (OMC) has been referred to offer an SPF of ca. 1.5. It
is nevertheless expected that the loading of OMC into SLN increases the
SPF by a synergistic effect, as SLN have already demonstrated scattering
capacity. For the Parsol-SLN-Si, a SPF value of 10.62 has been obtained
applying the Mansur equation. It is estimated that the scattering capacity
of SLN could be reinforced by the coating with silica, which together with
Parsol promoted the increasing of SPF. Similar results have been reported
by Barbosa et al. who, upon loading poly-ϵ-caprolactone nanocapsules of
SPF 6.84 with carrot oil, reached a SPF value of 8.64 [7]. Dutra et al. has
shown that when combining octyl methoxycinnamate with other clas-
sical chemical or physical sunscreens (such as benzophenone-3, titanium
dioxide, alkylbenzoate, octyl salicylate) in semi-solid formulations as
emulsions the SPF can reach values above 15 [43]. Our developed
semi-solid formulation, based on the dispersion of Parsol-SLN-Si in Car-
bopol hydrogels may further be improved with respect to its sun-blocking
capacity by formulating additional sunscreens in the hydrogel.
4. Conclusions
Hybrid nanoparticles composed of lipids and silica have been pro-
posed as a prominent delivery system for octyl methoxycinnamate. The
loading of the sunscreen into cetyl palmitate-SLN has been confirmed by
analysis of particle size parameters and by DSC. Particles remain physi-
cochemically stable when stored at 25 C over a period of 30 days. The
coating of particles with colloidal silica contributed for the improvement
of bioadhesiveness of the developed hydrogels. Hydrogels exhibited
properties for topical administration and did not induce irritation effects
on the HET-CAM. Further studies are planned to further evaluate the
effect on the bioadhesion with increasing concentration of hybrid
nanoparticles, in comparison to plain hydrogels, to explore the bio-
adhesion cumulative effect after adding non-coated and silica-coated
SLN. The synergistic effect of the loading of Parsol into SLN in the in-
crease of the SPF has also been demonstrated.
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